Ghent, Belgium: 8 November 2018 – Sequana Medical nv, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders, announces today the appointments of Pierre Chauvineau as Chairman and Wim Ottevaere as non-executive director of the Company effective as of the closing of the intended Initial Public Offering announced today. Pierre will succeed Rudy Dekeyser as Chairman, who will remain a non-executive director.

More info on Sequana’s website.

Categories: Personalia

Tags:

About the Author